Home page > News and press release

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data
Chiesi acquires pioneering therapeutic monoclonal antibodies portfolio against...
New investment will progress potential treatment of pulmonary arterial hypertension (PAH), a rare condition which causes high blood pressure and remodeling in the blood vessels that supply the...
Chiesi accelerates path toward full sustainability despite Covid-19 pandemic
Chiesi Group calls for #ActionOverWords in the fight against climate change
Chiesi continues cultural transformation with new visual identity that mirrors patients’ language and experiences
Chiesi Group receives the European marketing authorisation for Trimbow® (beclometasone dipropionate, formoterol fumarate, glycopyrronium) an extrafine formulation fixed triple combination therapy for the treatment of asthma
Chiesi Group increases support measures and announces new funds for employees, patients and healthcare providers in response to COVID- 19 pandemic
Chiesi Group Announces Establishment of New Global Rare Diseases Division